2272886-41-4
2272886-41-4
Chemical Structure
Omadacycline-d9
Synonym(s): PTK 0796-d9; Amadacycline-d9
- CAS No.: 2272886-41-4
- Formula:C29H31D9N4O7
- Molecular Weight:565.71
InChIKey: JEECQCWWSTZDCK-MYKRUONFSA-N
SMILES: O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C(CNCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N
Biological Activity: Omadacycline-d9 (PTK 0796-d9; Amadacycline-d9) is the deuterium labeled Omadacycline (HY-14865) that can be used as the internal standard for the analysis of Omadacycline[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Omadacycline-d9 | 99.21% | Omadacycline-d9 (PTK 0796-d9; Amadacycline-d9) is the deuterium labeled Omadacycline (HY-14865) that can be used as the internal standard for the analysis of Omadacycline. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Omadacycline (Standard) | ≥98% | Omadacycline (Standard) is the analytical standard of Omadacycline. This product is intended for research and analytical applications. Omadacycline (PTK 0796), a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Omadacycline | 99.85% | Omadacycline (PTK 0796), a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
